|
Originally published In Press as doi:10.1074/jbc.M112337200 on June 27, 2002
J. Biol. Chem., Vol. 277, Issue 36, 33369-33377, September 6, 2002
Detoxification of Cholera Toxin without Removal of Its
Immunoadjuvanticity by the Addition of (STa-related) Peptides to
the Catalytic Subunit
A POTENTIAL NEW STRATEGY TO GENERATE IMMUNOSTIMULANTS FOR
VACCINATION*
Joaquín
Sánchez §¶,
Gun
Wallerström ,
Margareta
Fredriksson ,
Jonas
Ångström , and
Jan
Holmgren
From the Department of Medical Microbiology and
Immunology, Göteborg University and the Göteborg University
Vaccine Research Institute, Guldhedsgatan 10A, Göteborg SE 413 46, Sweden, the § Facultad de Medicina, Universidad
Autónoma del Estado de Morelos, Avenida Universidad 1001, Colonia
Chamilpa, Cuernavaca, Morelos, CP62210, Mexico, and the
Institute of Medical Biochemistry, Göteborg
University, P. O. Box 440, Göteborg SE 405 30, Sweden
Peptides related to the heat-stable
enterotoxin STa were fused to the N terminus of the A-subunit of
cholera toxin (CTA) to explore whether peptide additions could help
generate detoxified cholera toxin (CT) derivatives. Proteins carrying
APRPGP (6-CTA), ASRCAELCCNPACPAP (16-CTA), or
ANSSNYCCELCCNPACTGCYPGP (23-CTA) were genetically constructed.
Using a two-plasmid system these derivatives were co-expressed in
Vibrio cholerae with cholera toxin B-subunit (CTB) to allow
formation and secretion of holotoxin-like molecules (engineered CT,
eCTs). Purified eCTs maintained all normal CT properties yet they were
more than 10-fold (eCT-6), 100-fold (eCT-16), or 1000-fold (eCT-23)
less enterotoxic than wild-type CT. The inverse correlation between
enterotoxicity and peptide length indicated sterical interference with
the ADP-ribosylating active site in CTA. This interpretation agreed
with greater than 1000-fold reductions in cAMP induction, with
reductions, albeit not proportional, in in vitro agmatine
ADP-ribosylation, and was supported by molecular simulations.
Intranasal immunization of mice demonstrated that eCTs retained their
inherent immunogenicity and ability to potentiate immune responses to a
co-administered heterologous protein antigen, although in variable
degrees. Therefore, the addition of STa-related peptides to CTA reduced
the toxicity of CT while partly preserving its natural
immunoadjuvanticity. These results suggest peptide extensions to CTA
are a useful alternative to site-directed mutagenesis to detoxify CT.
The simplicity of the procedure, combined with efficient expression and
assembly of derivatives, suggests this approach could allow for large
scale production of detoxified, yet immunologically active CT molecules.
*
This work was supported in part by Swedish Research Council
(Medicine) Project K2001-06 X03382 (to J. H.), by a grant
from SILANES, Sociedad Anónima de Capital Variable (S. A. de C. V.), Mexico (to J. S.), and by grants (to the Göteborg
University Vaccine Research Institute) from the Knut and Alice
Wallenberg Foundation.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
Recipient of a visiting professorship stipend from the Swedish
Foundation for International Cooperation in Research and Higher Education and member of the Sistema Nacional de Investigadores, Mexico.
To whom all correspondence should be addressed: Facultad de Medicina,
Universidad Autónoma del Estado de Morelos, Av. Universidad 1001, Col. Chamilpa, Cuernavaca, Morelos CP62210, Mexico. Tel.:
52-777-3297913; Fax: 52-777-3297998; E-mail:
joaquin.sanchez@ microbio.gu.se.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. K. Tinker, J. L. Erbe, and R. K. Holmes
Characterization of Fluorescent Chimeras of Cholera Toxin and Escherichia coli Heat-Labile Enterotoxins Produced by Use of the Twin Arginine Translocation System
Infect. Immun.,
June 1, 2005;
73(6):
3627 - 3635.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|